Impact of Weight-Loss Medications on the Cardiovascular System: Focus on Current and Future Anti-Obesity Drugs

Author： Drolet Benoit   Simard Chantale   Poirier Paul  

Publisher： Adis International

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.7, Iss.4, 2007-01, pp. : 273-288

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The differing mechanisms of action of anti-obesity agents determines their varying impact on the cardiovascular system

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 24, Iss. 8, 2008-08 ,pp. : 19-21

Adis International

Access to resources Recommend Favorite

Novel anti-obesity drugs

By Proietto J.   Fam B.C.   Ainslie D.A.   Thorburn A.W.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 6, 2000-06 ,pp. : 1317-1326

Informa Healthcare

Access to resources Recommend Favorite

Sibutramine: current status as an anti-obesity drug and its future perspectives

By Sharma Bikash   Henderson David C  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 12, 2008-08 ,pp. : 2161-2173

Informa Healthcare

Access to resources Recommend Favorite

Clinical Evaluation of Anti-Obesity Drugs

By  

Current Drug Targets, Vol. 5, Iss. 3, 2004-04 ,pp. : 325-332

Bentham Science Publishers

Access to resources Recommend Favorite

Fat Pills for Obesity's Ills: Novel Weight-Loss Drugs Emerging from the Pipeline

By Adis International Limited  

Pharmaceutical & Diagnostic Innovation, Vol. 4, Iss. 2, 2006-01 ,pp. : 7-9

Adis International

Access to resources Recommend Favorite